Pressmeddelande

Arctic Bioscience – Mandatory notification of trade

Cision Publicerad: 18 Oct 11:41

Siglar AS, a legal person closely associated with a person discharging managerial responsibility in Arctic Bioscience, has today bought 20,000 shares in Arctic Bioscience at an average price of NOK 2,32 per share. Following the transaction, Siglar AS holds 20,000 shares in Arctic Bioscience. In addition, Siglar AS holds 50% ownership of Capra Invest AS, which holds 1,544,450 in Arctic Bioscience.

Chairman of the Board at Arctic Bioscience, Harald Nordal, is the owner of Siglar AS.

Please refer to the attached notification of trading for further details.

This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 and the Norwegian Securities Trading Act § 5-12.

Bifogade filer

20241018 - Appendix 3 - Notifying Transactions - Siglar AShttps://mb.cision.com/Public/20422/4053357/b417ee392e18a279.pdf

Nyheter om Arctic Bioscience

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!